Fosinopril Sodium Articles
SOBI gains distribution rights for Megace, Monopril, Cefzil and Duricef from PharmaSwiss
13 February 2013
PharmaSwiss opens new Serbian plant
16 October 2006
Andrx' 1st-qtr 15% revenue fall, loss better
15 May 2006
FDA OKs Ranbaxy's generic fosinopril
10 January 2005
Stock Commentary - New York
20 December 2004
B-MS reports 1st-qtr earnings jump 22%
3 May 2004
B-MS "may sue" Canada over patents
28 September 2000
Healthy full-year results for many US pharmaceutical companies
27 January 2000
Healthy Third-Quarter Growth For US Drug Majors
22 October 1998
Australia Excludes SSRIs From Final TGP Scheme
17 December 1997
Significant Increases For US Drug Firms In 1996
3 February 1997
Sales Team Expands At Bristol-Myers Squibb
16 September 1996
Volume Growth Boosts B-MS' First Quarter
6 May 1996
Mixed Results For Q4 1995 From US Drug Majors
29 January 1996
Bristol-Myers Squibb Has "Best Combo Of Businesses"
20 February 1995
Solid 3rd Qtr Growth For Large Pharma Cos
31 October 1994
CURRENCIES STILL A FACTOR IN US 1st QTR
2 May 1994
STRONG DOLLAR WEAKENS US 1993 RESULTS
31 January 1994
US 3rd QTR AFFECTED BY STRONG DOLLAR
1 November 1993
US DRUGSTORE AUDIT DATA FOR JULY
6 September 1993
B-MS' MONOPRIL APPROVED IN CANADA
15 June 1992
STRONG INCREASES IN 1991 AT BRISTOL-MYERS SQUIBB
20 April 1992
US FDA BEATS 1990 DRUG APPROVALS IN 1991
13 January 1992
Showing 1-29 of 29 articles
- 1
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
